AVTR
Get informed when a big investor buys or sells
+ FollowOvervalued by 5.3% based on the discounted cash flow analysis.
| Market cap | $10.50 Billion |
|---|---|
| Enterprise Value | $10.23 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.78 |
| Beta | 0.9 |
| Outstanding Shares | 676,200,000 |
| P/E Ratio | -18.5 |
|---|---|
| PEG | 45 |
| Price to Sales | - |
| Price to Book Ratio | 1.85 |
| Enterprise Value to Revenue | 1149.13 |
| Enterprise Value to EBIT | -38.8 |
| Enterprise Value to Net Income | -18 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.8398▼ 1825.80% |
|---|---|
| Total Calls | 440,000▼ 8.68% |
| Total Puts | 369,500▼ 95.98% |
Holdings and activity of institutional investors.
| Ownership % | 104.26%▲ 4.60% |
|---|---|
| Total Invested | $6.99B▲ 31.68% |
| Investors Holding | 470▲ 23.00% |
No data
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.